4460.06

COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS. TUMOR NECROSIS FACTOR ANTAGONISTS IN OLDER ADULTS WITH IBD: A NATIONWIDE COHORT STUDY

Date
May 23, 2022
Explore related products in the following collection: